Premium
DDAVP IN CHILDHOOD NOCTURNAL ENURESIS
Author(s) -
TUVEMO T.
Publication year - 1978
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.1978.tb16255.x
Subject(s) - enuresis , medicine , nocturnal , pediatrics
. A double‐blind study of 18 children aged 6–12 years suffering from primary nocturnal enuresis without signs of underlying organic disease is reported. 20 μg of DDAVP (desamino‐ d ‐arginine vasopressin, Minirin®) was given intranasally at bedtime. The effect was prompt and satisfactory in 8 children and relatively good in another 8 children. No adverse effects were noted. DDAVP is advocated for temporary use in children with nocturnal enuresis needing immediate help.